| Event Name | Second Annual Summit on Disclosure for Drug, Device, and Biotech Companies |
| Event Date(s) |
Thursday, March 04, 2010
to
Friday, March 05, 2010
|
| Event Location |
Onsite at the Renaissance Washington DC Hotel
Washington,
D.C.
U.S.A.
|
| Cost | n/a |
| Description | • How Disclosure and Transparency are Reshaping Pharmaceutical and Device Marketing and Compliance
• Update on the Physician Payments Sunshine Act
• Pushing the Envelope: What's Next for the States?
• The Evolving Role of the OIG
• How Disclosure Will Reshape State and Federal Enforcement Initiatives
• Early Lessons from Lilly and Merck's Initial Public Disclosures
• The Physician-Industry Relationship: Flaws and Solutions
• How to Manage New Clinical Trial Disclosure Requirements
• Capturing the Right Information and Ensuring Its Integrity
• Benchmarking Data: Comparing Your Practices to Those of Your Peers
• Industry Disclosure Best Practice Roundtable |
| Sponsor | n/a |
| Host Company | n/a |
| Contact Information |
Phone:
800-684-4549
Fax:
n/a
Email:
registration@hcconferences.com
|
| More Information |
|